Usefulness of serum unbound free fatty acid levels to predict death early in patients with ST-segment elevation myocardial infarction (from the Thrombolysis In Myocardial Infarction [TIMI] II trial).
Usefulness of serum unbound free fatty acid levels to predict death early in patients with ST-segment elevation myocardial infarction (from the Thrombolysis In Myocardial Infarction [TIMI] II trial).
复制标题
DOI:
10.1016/j.amjcard.2013.08.057
复制
发表时间:
2014-01-15
影响因子:
2.8
通讯作者:
Kleinfeld, Alan M.
中科院分区:
文献类型:
--
作者:
Huber, Andrew H.;Kampf, J. Patrick;Kwan, Thomas;Zhu, Baolong;Adams, Jesse, III;Kleinfeld, Alan M.
Circulating total free fatty acids (FFA) are elevated early in myocardial infarction (MI) and are associated with an increase in mortality. We investigated the association of serum unbound free fatty acids (FFAu) levels with mortality,in patients presenting with ST elevation myocardial infarction (STEMI) in the Thrombolysis in Myocardial Infarction (TIMI) II trial.TIMI II enrolled patients within 4 hours of chest pain. Patients were treated with recombinant tissue plasminogen activator within 1 hour of enrollment. The concentration of FFAu was evaluated in serum samplesfrom 1834 patients obtained at baseline, before therapy.FFAu was an independent risk factor for death as early as one day of hospitalization and continued to be an independent risk factor for the more than 3·8 years of follow up. When adjusted for other cardiovascular risk factors FFAu levels in the fourth as compared to the first quartile remained an independent risk factor for death due to MI (hazard ratio, 5.0; 95 % confidence interval, 1.9-13.0), to all cardiac death (hazard ratio, 2.4; confidence interval, 1.3-4.4) and to all cause death (hazard ratio, 1.9, confidence interval, 1.2-3.1).Females were twice as likely to be in the upper two FFAu quartiles and had approximately twice the rate of death as males. In conclusion, increased levels of FFAu are one of the earliest molecular biomarkers of mortality in STEMI and are independent of other risk factors known to affect outcomes in STEMI.
登录
查看更多内容
影响因子:
168.9
作者:
GUPTA, DK;JEWITT, DE;OPIE, LH
通讯作者:
OPIE, LH
影响因子:
2.8
作者:
Kleinfeld, AM;Prothro, D;DeMaria, A
通讯作者:
DeMaria, A
影响因子:
39.3
作者:
Pilz, Stefan;Scharnagl, Hubert;Maerz, Winfried
通讯作者:
Maerz, Winfried
DOI:
10.2147/dmso.s37830
发表时间:
2013
期刊:
Diabetes, metabolic syndrome and obesity : targets and therapy
影响因子:
--
作者:
Gruzdeva O;Uchasova E;Dyleva Y;Belik E;Kashtalap V;Barbarash O
通讯作者:
Barbarash O
影响因子:
4.8
作者:
Bhardwaj, Anju;Truong, Quynh A.;Januzzi, James L., Jr.
通讯作者:
Januzzi, James L., Jr.